Industry: Chemical & Material
Published Date: 2025-05-25
Pages: 80 Pages
Report ld: 4214949
Request Sample
Customized Report
Reduced Glutathione (GSH) Market Size(US$)

CAGR 2025-2031
3.5%
Market Size,2031
USD 184
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Reduced Glutathione (GSH) market size was US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Reduced Glutathione (GSH) market competitiveness, regional economic performance, and supply chain configurations.
Reduced Glutathione (GSH) is a tripeptide compound composed of glutamic acid, cysteine, and glycine, widely present in human cells and one of the most important antioxidants in the body. GSH plays multiple key roles within cells, including antioxidant activity, maintaining intracellular homeostasis, detoxification, and involvement in cell signaling. It neutralizes free radicals and protects cells from oxidative damage, which is crucial for maintaining normal cell function and health. In the medical field, Reduced Glutathione is used to treat various diseases, such as liver diseases, cardiovascular diseases, and neurological disorders, due to its significant effects in antioxidant and cell protection. With increasing research into health and antioxidants, the applications of Reduced Glutathione in nutritional supplements, cosmetics, and food additives are also expanding, making it an important subject in modern medicine and health.
Market Development Opportunities & Main Driving Factors
With increasing public attention to health, the market for Reduced Glutathione (GSH) has witnessed broad development opportunities. In the medical field, GSH is widely used to treat liver diseases, cardiovascular diseases, and neurological disorders due to its significant antioxidant and cell - protective effects. As population aging intensifies and the incidence of chronic diseases rises, the demand for GSH is also increasing. Additionally, in the nutritional supplement market, consumer demand for natural antioxidants continues to rise, and GSH, as an efficient antioxidant, is gaining favor with more consumers. In the cosmetics industry, GSH is also used in anti - aging products because it can neutralize free radicals, reduce skin oxidative damage, and delay skin aging. With technological progress and improvements in production processes, the production cost of GSH is gradually decreasing, making its application in more fields possible and further driving market growth.
Market Challenges, Risks, & Restraints
Despite its huge potential, the GSH market also faces some challenges and risks. First, product quality and stability are key issues. GSH is prone to oxidation during production and storage, affecting its bioactivity and efficacy. Therefore, companies need to strictly control the production process to ensure product quality. Secondly, market competition is becoming increasingly fierce, with more and more companies entering the field, leading to intensified competition for market share. Companies need to continuously enhance their competitiveness in product quality, price, brand, and sales channels to cope with intense market competition. Moreover, changes in regulations and policies also have a certain impact on the GSH market. The food and pharmaceutical industries are subject to strict regulatory oversight, and adjustments in regulations and policies may increase compliance costs for companies and even affect product production and sales.
Downstream Demand Trends
Looking at downstream demand, GSH has broad application prospects in multiple fields. In the medical field, with increasing attention to the treatment of chronic diseases and in - depth research into antioxidant therapies, the application of GSH in the treatment of liver diseases, cardiovascular diseases, and neurological disorders will be even broader. In the nutritional supplement market, as consumer attention to health and antioxidants continues to rise, the market demand for GSH as an efficient antioxidant will continue to grow. In the cosmetics industry, with increasing consumer demand for natural ingredients and anti - aging products, the application of GSH in high - end cosmetics will be further expanded. In the future, with increasing public attention to health and in - depth research into natural antioxidants, the application fields and market potential of GSH will be further expanded.
The global Reduced Glutathione (GSH) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Reduced Glutathione (GSH) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Cosmetic Grade in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Food Industry in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Reduced Glutathione (GSH) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Reduced Glutathione (GSH) Product Scope
1.2 Reduced Glutathione (GSH) by Type
1.2.1 Global Reduced Glutathione (GSH) Sales by Type (2020 & 2024 & 2031)
1.2.2 Food Grade
1.2.3 Cosmetic Grade
1.2.4 Pharmaceutical Grade
1.3 Reduced Glutathione (GSH) by Application
1.3.1 Global Reduced Glutathione (GSH) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pharmaceuticals
1.3.3 Food Industry
1.3.4 Health Care Products
1.3.5 Other
1.4 Global Reduced Glutathione (GSH) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Reduced Glutathione (GSH) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Reduced Glutathione (GSH) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Reduced Glutathione (GSH) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Reduced Glutathione (GSH) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Reduced Glutathione (GSH) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Reduced Glutathione (GSH) Sales Market Share by Region (2020-2025)
2.2.2 Global Reduced Glutathione (GSH) Revenue Market Share by Region (2020-2025)
2.3 Global Reduced Glutathione (GSH) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Reduced Glutathione (GSH) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Reduced Glutathione (GSH) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Reduced Glutathione (GSH) Market Size and Prospective (2020-2031)
2.4.2 Europe Reduced Glutathione (GSH) Market Size and Prospective (2020-2031)
2.4.3 China Reduced Glutathione (GSH) Market Size and Prospective (2020-2031)
2.4.4 Japan Reduced Glutathione (GSH) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Reduced Glutathione (GSH) Historic Market Review by Type (2020-2025)
3.1.1 Global Reduced Glutathione (GSH) Sales by Type (2020-2025)
3.1.2 Global Reduced Glutathione (GSH) Revenue by Type (2020-2025)
3.1.3 Global Reduced Glutathione (GSH) Price by Type (2020-2025)
3.2 Global Reduced Glutathione (GSH) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Reduced Glutathione (GSH) Sales Forecast by Type (2026-2031)
3.2.2 Global Reduced Glutathione (GSH) Revenue Forecast by Type (2026-2031)
3.2.3 Global Reduced Glutathione (GSH) Price Forecast by Type (2026-2031)
3.3 Different Types Reduced Glutathione (GSH) Representative Players
4 Global Market Size by Application
4.1 Global Reduced Glutathione (GSH) Historic Market Review by Application (2020-2025)
4.1.1 Global Reduced Glutathione (GSH) Sales by Application (2020-2025)
4.1.2 Global Reduced Glutathione (GSH) Revenue by Application (2020-2025)
4.1.3 Global Reduced Glutathione (GSH) Price by Application (2020-2025)
4.2 Global Reduced Glutathione (GSH) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Reduced Glutathione (GSH) Sales Forecast by Application (2026-2031)
4.2.2 Global Reduced Glutathione (GSH) Revenue Forecast by Application (2026-2031)
4.2.3 Global Reduced Glutathione (GSH) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Reduced Glutathione (GSH) Application
5 Competition Landscape by Players
5.1 Global Reduced Glutathione (GSH) Sales by Players (2020-2025)
5.2 Global Top Reduced Glutathione (GSH) Players by Revenue (2020-2025)
5.3 Global Reduced Glutathione (GSH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reduced Glutathione (GSH) as of 2024)
5.4 Global Reduced Glutathione (GSH) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Reduced Glutathione (GSH), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Reduced Glutathione (GSH), Product Type & Application
5.7 Global Key Manufacturers of Reduced Glutathione (GSH), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Reduced Glutathione (GSH) Sales by Company
6.1.1.1 North America Reduced Glutathione (GSH) Sales by Company (2020-2025)
6.1.1.2 North America Reduced Glutathione (GSH) Revenue by Company (2020-2025)
6.1.2 North America Reduced Glutathione (GSH) Sales Breakdown by Type (2020-2025)
6.1.3 North America Reduced Glutathione (GSH) Sales Breakdown by Application (2020-2025)
6.1.4 North America Reduced Glutathione (GSH) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Reduced Glutathione (GSH) Sales by Company
6.2.1.1 Europe Reduced Glutathione (GSH) Sales by Company (2020-2025)
6.2.1.2 Europe Reduced Glutathione (GSH) Revenue by Company (2020-2025)
6.2.2 Europe Reduced Glutathione (GSH) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Reduced Glutathione (GSH) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Reduced Glutathione (GSH) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Reduced Glutathione (GSH) Sales by Company
6.3.1.1 China Reduced Glutathione (GSH) Sales by Company (2020-2025)
6.3.1.2 China Reduced Glutathione (GSH) Revenue by Company (2020-2025)
6.3.2 China Reduced Glutathione (GSH) Sales Breakdown by Type (2020-2025)
6.3.3 China Reduced Glutathione (GSH) Sales Breakdown by Application (2020-2025)
6.3.4 China Reduced Glutathione (GSH) Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Reduced Glutathione (GSH) Sales by Company
6.4.1.1 Japan Reduced Glutathione (GSH) Sales by Company (2020-2025)
6.4.1.2 Japan Reduced Glutathione (GSH) Revenue by Company (2020-2025)
6.4.2 Japan Reduced Glutathione (GSH) Sales Breakdown by Type (2020-2025)
6.4.3 Japan Reduced Glutathione (GSH) Sales Breakdown by Application (2020-2025)
6.4.4 Japan Reduced Glutathione (GSH) Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Kyowa Hakko Bio
7.1.1 Kyowa Hakko Bio Company Information
7.1.2 Kyowa Hakko Bio Business Overview
7.1.3 Kyowa Hakko Bio Reduced Glutathione (GSH) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Kyowa Hakko Bio Reduced Glutathione (GSH) Products Offered
7.1.5 Kyowa Hakko Bio Recent Development
7.2 Sigma-Aldrich
7.2.1 Sigma-Aldrich Company Information
7.2.2 Sigma-Aldrich Business Overview
7.2.3 Sigma-Aldrich Reduced Glutathione (GSH) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Sigma-Aldrich Reduced Glutathione (GSH) Products Offered
7.2.5 Sigma-Aldrich Recent Development
7.3 Cayman Chemical
7.3.1 Cayman Chemical Company Information
7.3.2 Cayman Chemical Business Overview
7.3.3 Cayman Chemical Reduced Glutathione (GSH) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Cayman Chemical Reduced Glutathione (GSH) Products Offered
7.3.5 Cayman Chemical Recent Development
7.4 Santa Cruz Biotechnology
7.4.1 Santa Cruz Biotechnology Company Information
7.4.2 Santa Cruz Biotechnology Business Overview
7.4.3 Santa Cruz Biotechnology Reduced Glutathione (GSH) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Santa Cruz Biotechnology Reduced Glutathione (GSH) Products Offered
7.4.5 Santa Cruz Biotechnology Recent Development
7.5 Shandong Jincheng Biological Pharmaceutical
7.5.1 Shandong Jincheng Biological Pharmaceutical Company Information
7.5.2 Shandong Jincheng Biological Pharmaceutical Business Overview
7.5.3 Shandong Jincheng Biological Pharmaceutical Reduced Glutathione (GSH) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Shandong Jincheng Biological Pharmaceutical Reduced Glutathione (GSH) Products Offered
7.5.5 Shandong Jincheng Biological Pharmaceutical Recent Development
7.6 GSH World
7.6.1 GSH World Company Information
7.6.2 GSH World Business Overview
7.6.3 GSH World Reduced Glutathione (GSH) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 GSH World Reduced Glutathione (GSH) Products Offered
7.6.5 GSH World Recent Development
7.7 Kaiping Genuine Biochemical Pharmaceutical
7.7.1 Kaiping Genuine Biochemical Pharmaceutical Company Information
7.7.2 Kaiping Genuine Biochemical Pharmaceutical Business Overview
7.7.3 Kaiping Genuine Biochemical Pharmaceutical Reduced Glutathione (GSH) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Kaiping Genuine Biochemical Pharmaceutical Reduced Glutathione (GSH) Products Offered
7.7.5 Kaiping Genuine Biochemical Pharmaceutical Recent Development
8 Reduced Glutathione (GSH) Manufacturing Cost Analysis
8.1 Reduced Glutathione (GSH) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Reduced Glutathione (GSH)
8.4 Reduced Glutathione (GSH) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Reduced Glutathione (GSH) Distributors List
9.3 Reduced Glutathione (GSH) Customers
10 Reduced Glutathione (GSH) Market Dynamics
10.1 Reduced Glutathione (GSH) Industry Trends
10.2 Reduced Glutathione (GSH) Market Drivers
10.3 Reduced Glutathione (GSH) Market Challenges
10.4 Reduced Glutathione (GSH) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Reduced Glutathione (GSH) market size was US$ 149 million in 2025 and is forecast to reach a readjusted size of US$ 189 million by 2032 with a CAGR of 3.5% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 80
USD 4250.00
(Single User License)
The global Reduced Glutathione (GSH) market is projected to grow from US$ 149 million in 2025 to US$ 189 million by 2032, at a CAGR of 3.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 148
USD 4900.00
(Single User License)
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 149 million in 2025 and is projected to reach US$ 189 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 108
USD 3950.00
(Single User License)
The global Reduced Glutathione (GSH) market was valued at US$ 149 million in 2025 and is anticipated to reach US$ 189 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 131
USD 2900.00
(Single User License)
The global Reduced Glutathione (GSH) market is projected to grow from US$ 145 million in 2024 to US$ 184 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 149
USD 4900.00
(Single User License)
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-05-25
Pages: 102
USD 3950.00
(Single User License)
The global Reduced Glutathione (GSH) market is projected to grow from US$ 149 million in 2025 to US$ 184 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published Date: 2025-05-25
Pages: 149
USD 4900.00
(Single User License)
The global market for Reduced Glutathione (GSH) was valued at US$ 145 million in the year 2024 and is projected to reach a revised size of US$ 184 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published Date: 2025-05-25
Pages: 95
USD 2900.00
(Single User License)
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 106
USD 3950.00
(Single User License)
The global Reduced Glutathione (GSH) market is projected to grow from US$ 140.3 million in 2024 to US$ 172.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published Date: 2024-04-15
Pages: 95
USD 4900.00
(Single User License)
The global Reduced Glutathione (GSH) market size was US$ 149 million in 2025 and is forecast to reach a readjusted size of US$ 189 million by 2032 with a CAGR of 3.5% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 80
The global Reduced Glutathione (GSH) market is projected to grow from US$ 149 million in 2025 to US$ 189 million by 2032, at a CAGR of 3.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 148
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 149 million in 2025 and is projected to reach US$ 189 million, growing at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 108
The global Reduced Glutathione (GSH) market was valued at US$ 149 million in 2025 and is anticipated to reach US$ 189 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Published: 2026-03-05
Pages: 131
The global Reduced Glutathione (GSH) market is projected to grow from US$ 145 million in 2024 to US$ 184 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 149
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-05-25
Pages: 102
The global Reduced Glutathione (GSH) market is projected to grow from US$ 149 million in 2025 to US$ 184 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published: 2025-05-25
Pages: 149
The global market for Reduced Glutathione (GSH) was valued at US$ 145 million in the year 2024 and is projected to reach a revised size of US$ 184 million by 2031, growing at a CAGR of 3.5% during the forecast period.
Published: 2025-05-25
Pages: 95
The global market for Reduced Glutathione (GSH) was estimated to be worth US$ 145 million in 2024 and is forecast to a readjusted size of US$ 184 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 106
The global Reduced Glutathione (GSH) market is projected to grow from US$ 140.3 million in 2024 to US$ 172.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.
Published: 2024-04-15
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now